Horizon Pharma To Buy Hyperion Therapeutics For $955.7 Million In A Cash And Debt Deal By: TalkMarkets March 30, 2015 at 18:24 PM EDT The acquisition is designed to bolster the pipeline with two drugs that treat a rare disease. HZNP up 18.2%. Read More >> Related Stocks: Horizon Therapeutics